辛伐他汀对血液透析患者血浆组织因子和组织因子途径抑制物的影响

doi:10.3969/j.issn.10073205.2017.04.005

摘要/Abstract

摘要： ［摘要］〓
〖HTH〗目的〖HTSS〗〖KG*2〗观察辛伐他汀对血液透析患者血浆组织因子血浆组织因子（tissue factor,TF）和组织因子途径抑制物(tissue factor pathway inhibitor, TFPI)的影响，探讨辛伐他汀在血液透析患者治疗中的应用价值。
〖HTH〗方法〖HTSS〗〖KG*2〗选择行血液透析治疗的慢性肾功能不全患者90例，依据随机数字法分为常规治疗组和辛伐他汀组，并选取同期体检的50例健康人群作为对照组，比较治疗前后TF、TFPI水平及血脂水平［三酰甘油（triglyceride，TG)、总胆固醇(total cholesterol，TC)、高密度脂蛋白胆固醇(high density lipoprotein cholesterol，HDLC)和低密度脂蛋白胆固醇(low density lipoprotein cholesterol，LDLC）］变化。
〖HTH〗结果〖HTSS〗〖KG*2〗肾功能不全患者TF和TFPI水平明显高于对照组（P＜005）。治疗后辛伐他汀组和常规治疗组TF水平明显低于治疗前，TFPI水平明显高于治疗前，辛伐他汀组TF和TPPI水平低于常规治疗组（P＜005）, 辛伐他汀组和常规治疗组TG、TC、LDLC明显低于治疗前，HDLC明显高于治疗前，辛伐他汀组TG、TC、LDLC明显低于常规治疗组，HDLC明显高于常规治疗组（P＜005），2组不良反应发生率差异无统计学意义（P＞005）。Pearson相关性分析表明，TF、TPPI水平与TG、TC、HDLC、LDLC均无相关性（P＞005）。
〖HTH〗结论〖HTSS〗〖KG*2〗20 mg辛伐他汀治疗维持性血液透析患者，能够降低TF、升高TFPI，对于纠正血液透析患者凝血功能紊乱具有重要意义。

关键词: 肾功能不全, 肾透析, 辛伐他汀, 凝血致活酶

Abstract: ［Abstract］ Objective〖HTSS〗〓To observe the effect of simvastatin on plasma tissue factor and tissue factor pathway inhibitor in hemodialysis patients,and to explore the value of simvastatin in the treatment of hemodialysis patients.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓Ninety cases of chronic renal failure patients with hemodialysis treatment were randomly divided into conventional treatment group and simvastatin treatment group, and 50 cases healthy people received in the same period as control group. Plasma tissue factor(TF), tissue factor pathway inhibitor(TFPI) activity and blood lipid level triglyceride(TG), total cholesterol(TC), high density lipoprotein cholesterol(HDLC) and low density lipoprotein cholesterol(LDLC) changes before and after treatment were compared.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓TF and TFPI activity in chronic renal failure patients were significantly higher than those in control group(P＜005) . TF levels after treatment in two groups were significant lower than before, and TFPI levels were significant higher than before,but TF and TFPI activity in simvastatin treatment group was significantly lower than conventional treatment group(P＜005). TG, TC and LDLC in two groups after treatment were significantly lower than before, HDLC was higher than before,TG, TC and LDLC in the simvastatin treatment group were significantly lower than those in conventional treatment group, and the HDLC was significantly higher than that in conventional treatment group(P＜005), there was no significant difference in the incidence of adverse reactions between the two groups(P＞005). Pearson correlation analysis showed that TF and TPPI levels were not correlated with TG, TC, HDLC and LDLC(P＞005).
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓20 mg simvastatin treatment in maintenance hemodialysis patients can reduce the tissue factor activity, increase tissue factor pathway inhibitor level, which was important for correcting coagulation disorders in hemodialysis patients.

Key words: renal insufficiency； renal dialysis； simvastatin, thromboplastin

姚〓律1,2，郝〓丽1*，郭长策2，丁士新2. 辛伐他汀对血液透析患者血浆组织因子和组织因子途径抑制物的影响[J]. 河北医科大学学报, doi: 10.3969/j.issn.10073205.2017.04.005.

YAO Lv1,2, HAO Li1*, GUO Changce2, DING Shixin2. [J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.10073205.2017.04.005.

[1]	韩丽丽, 张平, 王芳, 陈珊珊, 扈瑞春, 张绍菊. FGF23、orexin A、BMP-7在肾衰竭患者中的表达水平及与临床预后的关系 [J]. 河北医科大学学报, 2023, 44(5): 512-516,546.
[2]	范甜甜（综述）, 马哲（审校）. 牙周炎通过脂代谢途径促进慢性肾病发生发展的研究进展 [J]. 河北医科大学学报, 2023, 44(5): 596-601.
[3]	高艳玲. HFHD联合西沙必利对慢性CRF患者的炎症因子、肾功能指标及临床疗效分析[J]. 河北医科大学学报, 2022, 43(8): 909-914.
[4]	卢海源, 蒋海涛, 史国辉, 王国乙. 老年慢性肾衰竭维持性血液透析患者褪黑素、AOPP水平与骨质疏松症的关系研究 [J]. 河北医科大学学报, 2022, 43(7): 763-767.
[5]	管仁苹, 尹立勇, 刘维萍, 李涛, 郭永力, 张彦芬. 维持性血液透析患者心脏瓣膜钙化对病死率的影响分析 [J]. 河北医科大学学报, 2022, 43(6): 637-640,675.
[6]	张文川. 铁调素/铁蛋白比值在预测维持性血液透析患者心功能的应用[J]. 河北医科大学学报, 2022, 43(5): 525-529.
[7]	翁晓羽, 陶明芬（综述), 徐姝娟, 马少勇（审校）. 血液透析患者血压变异性的临床应用与研究进展[J]. 河北医科大学学报, 2022, 43(2): 244-248,封三.
[8]	陶晓阳, 李花, 郁胜强. β-CTX、UA、FGF-23与慢性肾衰竭透析患者矿物质-骨异常的关系[J]. 河北医科大学学报, 2021, 42(5): 531-535.
[9]	高田, 王淦楠, 王巍, 张劲松. 横纹肌溶解综合征肌红蛋白、肌酸激酶及其比值对急性肾功能衰竭的预测分析[J]. 河北医科大学学报, 2021, 42(4): 386-389，400.
[10]	李欣悦, 耿巍, 刘素芬, 田祥. 高敏肌钙蛋白T对慢性肾衰竭非透析患者急性心肌梗死的诊断价值[J]. 河北医科大学学报, 2021, 42(1): 12-16.
[11]	韩碧翠1，张福1，林少强2. AKI肾穿刺活检术后肾周血肿与术前透析干预相关性研究[J]. 河北医科大学学报, 2020, 41(9): 1029-1032.
[12]	宋艳芳1，吴胜利2. 左卡尼汀联合超纯透析对MHD患者心功能及外周血irisin、s-Klotho表达的影响[J]. 河北医科大学学报, 2020, 41(6): 670-675.
[13]	王德琴, 缪娴静, 周永华, 崔益鸿, 陈宇, 高健. 高通量血液透析对维持性血液透析患者炎症、营养状态及颈动脉粥样硬化斑块的影响[J]. 河北医科大学学报, 2020, 41(12): 1472-1475.
[14]	刘洁琼，王景福*. 老年维持性血液透析患者穿透素3与超敏C反应蛋白和营养不良的关系[J]. 河北医科大学学报, 2019, 40(6): 654-657.
[15]	陈〓龙，成家友，王〓珊，周冬梅，王〓金. 司维拉姆联合依降钙素治疗血液透析患者高磷血症的效果观察[J]. 河北医科大学学报, 2019, 40(6): 658-661,666.

辛伐他汀对血液透析患者血浆组织因子和组织因子途径抑制物的影响

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价